Skip to main content
OpenTrials
Completed

NCT Number: NCT00559832

Prevention of Acute Mountain Sickness by Intermittent Hypoxia

Acclimatization by mountaineering prior to high altitude sojourns have shown to be effective in prevention of acute mountain sickness (AMS).

The aim of this study is to investigate whether intermittent exposure to normobaric hypoxia during sleep is also effective to prevent AMS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Sports Medicine, University Hospital

Heidelberg, 69120, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy

Exclusion criteria

  • Altitude exposure above 2000 m 8 weeks prior or during the study

Treatment and study plan

Hypoxic exposure

Other

Sleeping in normobaric hypoxia for 14 nights at altitudes from 2500 - 3300 m prior to one night at 4500 m

Primary outcomes

  1. incidence of acute mountain sickness

    Time frame: during one night at 4500 m

Secondary outcomes

  1. Sleep quality

    Time frame: during one night at altitude

  2. ventilatory acclimatization

    Time frame: during one night at altitude

Sponsors and collaborators

Lead sponsor

Heidelberg University

Other

Registry information

Official study title

Prevention of Acute Mountain Sickness by Sleeping at Simulated Altitude (Normobaric Hypoxia)

Important dates

Study start
2006
Study completion
2007
First posted
Nov 16, 2007
Registry last updated
Nov 16, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.